News of Note—ViewRay to trial MRIdian system in inoperable pancreatic cancer, and more

News of note

> ViewRay launched a prospective clinical trial for its MRI-guided radiation therapy system in locally advanced unresectable pancreatic cancer. Release | Read more about ViewRay

> Boston Scientific is rolling out its suite of MRI-conditional Resonate implantable cardioverter defibrillators. Release

> Novocure announced data from a phase 3 study showing that patients with newly diagnosed glioblastoma who underwent a combination treatment of its Optune device and the chemo drug temozolomide fared better than those who received temozolomide alone. Release


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Suggested Articles

The FDA has cleared Drawbridge Health’s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes.

FierceMedTech Fierce 15 winner 10x Genomics announced its plans for a $100 million IPO, on the Nasdaq using the symbol TXG.

Belgian devicemaker Miracor Medical received a breakthrough designation from the FDA for its treatment designed to limit the damage of a heart attack.